1
|
Chernyshov PV, Finlay AY, Tomas-Aragones L, Zuberbier T, Kocatürk E, Manolache L, Pustisek N, Svensson A, Marron SE, Sampogna F, Bewley A, Salavastru C, Koumaki D, Augustin M, Linder D, Abeni D, Salek SS, Szepietowski J, Jemec GB. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient-Oriented Outcomes and Urticaria and Angioedema. J Eur Acad Dermatol Venereol 2024. [PMID: 38855825 DOI: 10.1111/jdv.20157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2024] [Accepted: 05/03/2024] [Indexed: 06/11/2024]
Abstract
The European Academy of Dermatology and Venereology (EADV) Task Forces on quality of life (QoL) and patient-oriented outcomes and on urticaria and angioedema recommendations for the assessment of Health-related (HR) QoL in all patients with urticaria in research and practice are as follows: to use the DLQI for adults and the CDLQI for children as dermatology-specific and the CU-Q2oL as a disease-specific HRQoL instruments in urticaria; to use generic instruments to provide comparison of data on urticaria with non-dermatologic diseases, or to compare with healthy volunteers or the general population; to select validated HRQoL instruments with appropriate age limits; to present exact numeric data for HRQoL results; correct title of any HRQoL instrument should be used, along with its correct abbreviation and the reference to its original publication, where possible. The EADV TFs discourage the use of non-validated HRQoL instruments and modified HRQoL instruments that have not undergone standard validation.
Collapse
Affiliation(s)
- P V Chernyshov
- Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine
| | - A Y Finlay
- Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK
| | - L Tomas-Aragones
- Department of Psychology, University of Zaragoza, Zaragoza, Spain
| | - T Zuberbier
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany
| | - E Kocatürk
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany
- Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey
| | - L Manolache
- Department of Dermatology, Dali Medical, Bucharest, Romania
| | - N Pustisek
- Children's Hospital Zagreb, Zagreb, Croatia
| | - A Svensson
- Department of Dermatology and Venereology, Skane University Hospital, Malmö, Sweden
| | - S E Marron
- Department of Dermatology, University Hospital Miguel Servet, Aragon Psychodermatology Research Group (GAI+PD), Zaragoza, Spain
| | - F Sampogna
- Clinical Epidemiology Unit, IDI-IRCCS, Rome, Italy
| | - A Bewley
- Barts Health NHS Trust, London, UK
- Queen Mary University, London, UK
| | - C Salavastru
- Department of Paediatric Dermatology, Colentina Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania
| | - D Koumaki
- Department of Dermatology and Venereology, University Hospital of Heraklion, Heraklion, Crete, Greece
| | - M Augustin
- Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - D Linder
- University Clinic for Medical Psychology and Psychotherapy, Medical University of Graz, Graz, Austria
| | - D Abeni
- Clinical Epidemiology Unit, IDI-IRCCS, Rome, Italy
| | - S S Salek
- School of Life & Medical Sciences, University of Hertfordshire, Hatfield, UK
| | - J Szepietowski
- Department of Dermatology, Wroclaw Medical University, Wroclaw, Poland
| | - G B Jemec
- Department of Dermatology, Zealand University Hospital, Roskilde, Denmark
| |
Collapse
|
2
|
Chen X, Zhou X, Li H, Li J, Jiang H. The value of WeChat application in chronic diseases management in China. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE 2020; 196:105710. [PMID: 32858284 DOI: 10.1016/j.cmpb.2020.105710] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Accepted: 08/11/2020] [Indexed: 06/11/2023]
Abstract
The prevalence of chronic diseases in China has increased rapidly in recent decades. Although the management rate of chronic diseases has improved, there is still no unified and effective management measure for chronic diseases at present. This highlights the importance of effectively managing chronic diseases. With the development of e-health, the ways of getting medical consultation have changed. WeChat is an extremely popular social application in China. It is easy to operate and can offer multiple functions. Many researches have reported the effectiveness of WeChat in chronic diseases management. Based on the status of WeChat application in chronic diseases management and the characteristics of WeChat technology, we firstly focused on the WeChat application on the management of chronic diseases such as hypertension, diabetes, coronary heart disease and cancer. Then we discussed the value of WeChat in chronic diseases management and analyzed the potential reasons. Lastly, we discussed the limitations of present researches. WeChat can be an effective tool for the management of chronic diseases, but the promotion of this mode needs support and efforts from various aspects to eventually realize improving public health.
Collapse
Affiliation(s)
- Xin Chen
- Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
| | - Xi Zhou
- Department of General Practice, Shanghai East Hospital Ji An Hospital, Ji An, Jiangxi Provence, China
| | - Huan Li
- Department of General Practice, Shanghai East Hospital Ji An Hospital, Ji An, Jiangxi Provence, China
| | - Jinlan Li
- Department of General Practice, Shanghai East Hospital Ji An Hospital, Ji An, Jiangxi Provence, China
| | - Hua Jiang
- Department of General Practice, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China; Department of General Practice, Shanghai East Hospital Ji An Hospital, Ji An, Jiangxi Provence, China.
| |
Collapse
|
4
|
Ahmed S, Ware P, Visca R, Bareil C, Chouinard MC, Desforges J, Finlayson R, Fortin M, Gauthier J, Grimard D, Guay M, Hudon C, Lalonde L, Lévesque L, Michaud C, Provost S, Sutton T, Tousignant P, Travers S, Ware M, Gogovor A. The prevention and management of chronic disease in primary care: recommendations from a knowledge translation meeting. BMC Res Notes 2015; 8:571. [PMID: 26471509 PMCID: PMC4608115 DOI: 10.1186/s13104-015-1514-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2014] [Accepted: 09/21/2015] [Indexed: 12/29/2022] Open
Abstract
Background Seven chronic disease prevention and management programs were implemented across Quebec with funding support from a provincial-private industry funding initiative. Given the complexity of implementing integrated primary care chronic disease management programs, a knowledge transfer meeting was held to share experiences across programs and synthesize common challenges and success factors for implementation. Methods The knowledge translation meeting was held in February 2014 in Montreal, Canada. Seventy-five participants consisting of 15 clinicians, 14 researchers, 31 knowledge users, and 15 representatives from the funding agencies were broken up into groups of 10 or 11 and conducted a strengths, weaknesses, opportunities, and threats analysis on either the implementation or the evaluation of these chronic disease management programs. Results were reported back to the larger group during a plenary and recorded. Audiotapes were transcribed and summarized using pragmatic thematic analysis. Results and discussion Strengths to leverage for the implementation of the seven programs include: (1) synergy between clinical and research teams; (2) stakeholders working together; (3) motivation of clinicians; and (4) the fact that the programs are evidence-based. Weaknesses to address include: (1) insufficient resources; (2) organizational change within the clinical sites; (3) lack of referrals from primary care physicians; and (4) lack of access to programs. Strengths to leverage for the evaluation of these programs include: (1) engagement of stakeholders and (2) sharing of knowledge between clinical sites. Weaknesses to address include: (1) lack of referrals; (2) difficulties with data collection; and (3) difficulties in identifying indicators and control groups. Opportunities for both themes include: (1) fostering new and existing partnerships and stakeholder relations; (2) seizing funding opportunities; (3) knowledge transfer; (4) supporting the transformation of professional roles; (5) expand the use of health information technology; and (6) conduct cost evaluations. Fifteen recommendations related to mobilisation of primary care physicians, support for the transformation of professional roles, and strategies aimed at facilitating the implementation and evaluation of chronic disease management programs were formulated based on the discussions at this knowledge translation event. Conclusion The results from this knowledge translation day will help inform the sustainability of these seven chronic disease management programs in Quebec and the implementation and evaluation of similar programs elsewhere. Electronic supplementary material The online version of this article (doi:10.1186/s13104-015-1514-0) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Sara Ahmed
- Faculty of Medicine, School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Montreal, QC, H3G 1Y5, Canada. .,Constance-Lethbridge Rehabilitation Center, Centre de recherche interdisciplinaire en réadaptation (CRIR), 7005 Boulevard De Maisonneuve O, Montréal, Quebec, H4B 1T3, Canada. .,Clinical Epidemiology, McGill University Health Center, 687 Pine Ave W, Montreal, QC, H3A 1A1, Canada.
| | - Patrick Ware
- Faculty of Medicine, School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Montreal, QC, H3G 1Y5, Canada.
| | - Regina Visca
- Centre for Expertise in Chronic Pain of the Réseau universitaire intégré de santé McGill, 2155 Guy, Montreal, QC, H3H 2R9, Canada.
| | - Celine Bareil
- Department of Management, HEC Montreal, 3000, chemin de la Côte-Sainte-Catherine, Montreal, QC, H3T 2A7, Canada.
| | - Maud-Christine Chouinard
- Département des sciences de la santé, Université du Québec à Chicoutimi, 555 boul. de l'Université, Chicoutimi, QC, G7H 2B1, Canada. .,Centre de santé et de services sociaux de Chicoutimi, 305 St-Vallier, Chicoutimi, QC, G7H 5H6, Canada.
| | - Johanne Desforges
- Groupe de médecine de famille de Verdun, 4000, boulevard Lasalle, Verdun, QC, H4G 2A3, Canada.
| | - Roderick Finlayson
- Centre for Expertise in Chronic Pain of the Réseau universitaire intégré de santé McGill, 2155 Guy, Montreal, QC, H3H 2R9, Canada.
| | - Martin Fortin
- Centre de santé et de services sociaux de Chicoutimi, 305 St-Vallier, Chicoutimi, QC, G7H 5H6, Canada. .,Département de médecine de famille et médecine d'urgence, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 3001 12ème avenue Nord, Fleurimont, QC, J1H 5N4, Canada.
| | - Josée Gauthier
- Institut national de santé publique du Quebec, Consortium InterEst Santé, Département des sciences infirmières, Université du Québec à Rimouski, 300 Allée des Ursulines, Bureau K-310, Rimouski, QC, G5L 3A1, Canada.
| | - Dominique Grimard
- Direction de santé publique de l'Agence de la santé et des services sociaux de Montréal, 1301 Sherbrooke Est, Montreal, QC, H2L 1M3, Canada.
| | - Maryse Guay
- Département des sciences de la santé communautaire, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 3001 12e Avenue Nord, Sherbrooke, QC, J1H 5N4, Canada. .,Direction de santé publique de l'Agence de la santé et des services sociaux de la Montérégie, 1255 Beauregard, Longueuil, J4H 2M3, Canada.
| | - Catherine Hudon
- Département de médecine de famille et médecine d'urgence, Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 3001 12ème avenue Nord, Fleurimont, QC, J1H 5N4, Canada.
| | - Lyne Lalonde
- Faculté de pharmacie, Université de Montréal, pavillion Jean-Coutu, Montreal, QC, H3C 3J7, Canada. .,Centre de santé et de services sociaux de Laval, 1755 boulevard René-Laennec, Laval, QC, H7M 3L9, Canada.
| | - Lise Lévesque
- Centre de santé et de services sociaux de Laval, 1755 boulevard René-Laennec, Laval, QC, H7M 3L9, Canada.
| | - Cecile Michaud
- Faculté de médecine et des sciences de la santé, École des sciences infirmières, Université de Sherbrooke, Campus de Longueil, 150, Place Charles LeMoyne, Bureau 200, Sherbrooke, QC, J4K 0A8, Canada.
| | - Sylvie Provost
- Direction de santé publique de l'Agence de la santé et des services sociaux de Montréal, 1301 Sherbrooke Est, Montreal, QC, H2L 1M3, Canada.
| | - Tim Sutton
- Centre de santé et de services sociaux du Roché-Percé, 451, rue MGR-Ross Est, C.P. 3300, Chandler, QC, G0C 1K0, Canada.
| | - Pierre Tousignant
- Direction de santé publique de l'Agence de la santé et des services sociaux de Montréal, 1301 Sherbrooke Est, Montreal, QC, H2L 1M3, Canada.
| | - Stella Travers
- Centre de santé et de services sociaux du Roché-Percé, 451, rue MGR-Ross Est, C.P. 3300, Chandler, QC, G0C 1K0, Canada.
| | - Mark Ware
- Alan Edwards Pain Management Unit of the McGill University Health Centre, 650 Cedar Avenue, Montreal, QC, H3G 1A4, Canada.
| | - Amede Gogovor
- Faculty of Medicine, School of Physical and Occupational Therapy, McGill University, 3654 Prom Sir-William-Osler, Montreal, QC, H3G 1Y5, Canada.
| |
Collapse
|